Related Experiment Video

Updated: Aug 14, 2026

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone

Andrew H Gordon1, Regis J O'Keefe, Edward M Schwarz

  • 1Biomedical Engineering, University of Rochester, Rochester, NY 14642, USA.

Cancer Research
|April 19, 2005
PubMed

Insights

Nuclear factor-kappaB (NF-kappaB) signaling in breast cancer cells drives osteolytic bone tumors by promoting proliferation and bone resorption. Inhibiting NF-kappaB reduces tumor growth and osteolysis, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bone Biology

Background:

  • Nuclear factor-kappaB (NF-kappaB) is a key regulator of genes involved in cancer and bone destruction.
  • Understanding NF-kappaB's role in osteolytic bone tumors is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate how NF-kappaB signaling in breast cancer cells influences osteolytic bone tumor progression.
  • To evaluate the therapeutic potential of targeting NF-kappaB in osteolytic bone metastases.

Main Methods:

  • Stable infection of MDA-MB-231 breast cancer cells with a dominant-negative IkappaB mutant to block NF-kappaB signaling.
  • In vitro assays measuring cell proliferation, interleukin-6 expression, and osteoclast co-culture bone resorption.
  • In vivo studies involving intratibial injection of tumor cells in mice to assess osteolysis.
  • Immunohistochemistry to detect NF-kappaB and interleukin-6 expression at the bone-tumor interface.

Main Results:

  • Blocking NF-kappaB signaling decreased MDA-MB-231 cell proliferation and interleukin-6 production.
  • Inhibition of NF-kappaB reduced in vitro bone resorption and increased caspase-3 expression.
  • Suppression of NF-kappaB diminished in vivo tumor-induced osteolysis in mice.
  • NF-kappaB (p65 subunit) and interleukin-6 were expressed at the bone-tumor interface in cancerous lesions.

Conclusions:

  • NF-kappaB signaling in breast cancer cells is a critical driver of bone tumor burden and osteolysis.
  • NF-kappaB regulates tumor proliferation, survival, and bone resorption.
  • Targeting NF-kappaB and its associated genes represents a promising therapeutic strategy for osteolytic bone metastases.

More Related Videos

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche11:41

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Published on: March 15, 2015

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...